Cuprina Holdings (Cayman) Limited
CUPRNASDAQHealthcareMedical Instruments & Supplies

About Cuprina Holdings (Cayman)

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencySGD - SGD
TypeStock
Share ClassClass A Shares

Contact Information

Phone65 8512 7275
Address
Blk 1090, Lower Delta Road #06-08 Singapore, 169201 Singapore

Corporate Identifiers

CIK0001995704
CUSIPG2592E102
ISINKYG2592E1026
SIC3842

Leadership Team & Key Executives

Yong Qi Quek
Chief Executive Officer and Director
Tat Jing Chan
Chief Financial Officer
Dr. Ronald Sherman
Medical and Scientific Director
Dr. Naresh Waran Gnanasegaran
Head of Research & Development